RECOMMENDATION - BUY AT CMP / DECLINES
TARGET- 128 , STOP-98, TIME -T+14 DAYS (APPROX)
The mid cap pharma stocks have been showing quite a lot of traction lately. One such stock in this sector is Sun Pharma Advance Research - SPARC.
Wave 1 for this stock was relatively docile unlike its other pharma cousins. The current move to 108 has confirmed a breakout and hence the beginning of wave 3. Based on this fact the target for this stock is likely to be around 170 in this move. However, over the short term 128 seems to be the more reasonable expectation based on the width of the consolidation.
UPGRADE TO WAVE PRO AND GET TIMELY TRADING CALLS ON YOUR MOBILE (Rs 100 per call only)
Disclaimer : The recommendations mentioned herein are for educational purpose only. One should not take buy/sell decisions based on the above analysis which is prone to errors. The author does not undertake any liability whatsoever arising out of profits/losses accruing from using the above analysis.